What's new this month in BMJ JournalsBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7513.372 (Published 11 August 2005) Cite this as: BMJ 2005;331:372
- Harvey Marcovitch, BMJ syndication editor (email@example.com)
Adding mesalazine enemas improves outcome in extensive ulcerative colitis
A randomised placebo controlled trial has shown that adding a nightly mesalazine enema improves remission rates in patients with extensive ulcerative colitis who are already being treated with the oral preparation. After eight weeks, nearly 90% of those receiving combined treatment had improved (44% in remission) compared with under 70% of those having placebo enemas (34% in remission). Treatment was safe and well accepted, so should be considered as first line for those with colitis extending beyond the splenic flexure.
Log in using your username and password
Log in through your institution
Sign up for a free trial